Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Soc Neurosci ; 14(2): 149-161, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-29347878

RESUMO

Despite the accumulated knowledge on moral decision-making in the early stages of development, empirical evidence is still limited in the old-aged adults. The current study contributes to unveil the neural correlates of judgments of moral transgressions as a function of aging, by examining the temporal dynamics of neural activation elicited by intentional and accidental harmful actions in three groups of healthy participants: young adults (18-35), adults (40-55), and older adults (60-75). Older adults were slower and less accurate in rating intentionality, compared to the younger groups. In ERP analysis, the older group showed increased P2 amplitude, which was predicted by poorer performance on neuropsychological tests. Reduced amplitudes were found on critical ERP components to moral cognition (N2 and LPP), namely while processing intentional harmful scenarios. Older adults seem to allocate more attentional resources (P2) to the task, probably to compensate the age-related decline in executive functioning, while younger groups show a pronounced negativity while detecting harm (N2) and increased neural activation to encode the intentions behind the acts (LPP).


Assuntos
Envelhecimento/fisiologia , Tomada de Decisões/fisiologia , Princípios Morais , Percepção Social , Adulto , Idoso , Encéfalo/fisiologia , Eletroencefalografia , Potenciais Evocados/fisiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
2.
Cogn Affect Behav Neurosci ; 19(1): 109-122, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30341622

RESUMO

Aging is associated with changes in cognitive and affective functioning, which likely shape older adults' social cognition. As the neural and psychological mechanisms underlying age differences in social abilities remain poorly understood, the present study aims to extend the research in this field. To this purpose, younger (n = 30; Mage = 26.6), middle-aged (n = 30; Mage = 48.4), and older adults (n = 29; Mage = 64.5) performed a task designed to assess affective perspective-taking, during an EEG recording. In this task, participants decided whether a target facial expression of emotion (FEE) was congruent or incongruent with that of a masked intervener of a previous scenario, which portrayed a neutral or an emotional scene. Older adults showed worse performance in comparison to the other groups. Regarding electrophysiological results, while younger and middle-aged adults showed higher late positive potentials (LPPs) after FEEs congruent with previous scenarios than after incongruent FEEs, older adults had similar amplitudes after both. This insensitivity of older adults' LPPs in differentiating congruent from incongruent emotional context-target FEE may be related to their difficulty in generating information about others' inner states and using that information in social interactions.


Assuntos
Fatores Etários , Envelhecimento/fisiologia , Tomada de Decisões/fisiologia , Emoções/fisiologia , Adulto , Idoso , Comportamento/fisiologia , Feminino , Humanos , Relações Interpessoais , Masculino , Pessoa de Meia-Idade , Estimulação Luminosa/métodos , Adulto Jovem
3.
Neurosci Lett ; 692: 122-126, 2019 01 23.
Artigo em Inglês | MEDLINE | ID: mdl-30391319

RESUMO

This study examines age-related differences in behavioral and neural responses to unfairness. Our sample was composed of younger, middle-aged, and older adults, who performed the Ultimatum Game in the proposer role, and in the respondent role during an EEG recording. We administered neurocognitive tests to identify whether patterns in decision-making are associated with age-related changes in cognition. Despite the worse performance in measures of executive functioning, older adults had the best economic strategy by accepting more unfair offers than younger and middle-aged adults. Regarding electrophysiological results, while younger adults showed higher medial frontal negativity (MFN) amplitudes after unfair than after fair offers, middle-aged and older adults had similar amplitudes after both conditions. Our results suggest that aging may be accompanied by an insensitivity to unfairness, which may underlie their higher rates of unfair offers acceptance.


Assuntos
Envelhecimento , Encéfalo/fisiologia , Tomada de Decisões/fisiologia , Relações Interpessoais , Comportamento Social , Adulto , Eletroencefalografia , Jogos Experimentais , Humanos , Pessoa de Meia-Idade , Testes Neuropsicológicos , Adulto Jovem
4.
AIDS Care ; 28(9): 1149-53, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-26932511

RESUMO

The aim of our study was to evaluate the impact of coffee intake on cognitive function in persons living with HIV (PLWH). 130 PLWH with CD4 > 200 cells/mm(3), undetectable viral load, treated with HAART were included. A structured interview was applied and relevant clinical and laboratory data were assessed, including coffee intake. For neuropsychological assessment, the HIV Neurobehavioral Research Center Battery was chosen. Univariate nonparametric statistics and multivariate regression model were used. A significant association between espresso coffee use and a better cognitive function was verified in five of the eight psychometric measurements. In the multivariate analysis, after variable adjustment, linear regression analysis showed that coffee intake was a positive predictor for attention/working memory, executive functions and Global Deficit Score. Although the mechanisms behind the influence of caffeine on cognitive functioning are controversial, regular espresso coffee intake may have favourable effects on cognitive deterioration caused by HIV.


Assuntos
Cafeína/farmacologia , Café , Cognição/efeitos dos fármacos , Infecções por HIV/psicologia , Extratos Vegetais/farmacologia , Adulto , Terapia Antirretroviral de Alta Atividade , Atenção/efeitos dos fármacos , Transtornos Cognitivos/virologia , Função Executiva/efeitos dos fármacos , Feminino , Infecções por HIV/tratamento farmacológico , Humanos , Masculino , Memória de Curto Prazo/efeitos dos fármacos , Pessoa de Meia-Idade , Testes Neuropsicológicos , Psicometria , Análise de Regressão , Carga Viral
5.
Clin Neurophysiol ; 123(7): 1300-8, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22197447

RESUMO

OBJECTIVE: Conflicting reports of P200 amplitude and latency in schizophrenia have suggested that this component is increased, reduced or does not differ from healthy subjects. A systematic review and meta-analysis were undertaken to accurately describe P200 deficits in auditory oddball tasks in schizophrenia. METHODS: A systematic search identified 20 studies which were meta-analyzed. Effect size (ES) estimates were obtained: P200 amplitude and latency for target and standard tones at midline electrodes. RESULTS: The ES obtained for amplitude (Cz) for standard and target stimuli indicate significant effects in opposite directions: standard stimuli elicit smaller P200 in patients (d = -0.36; 95% CI [-0.26, -0.08]); target stimuli elicit larger P200 in patients (d = 0.48; 95% CI [0.16, 0.82]). A similar effect occurs for latency at Cz, which is shorter for standards (d = -0.32; 95% CI [-0.54, -0.10]) and longer for targets (d = 0.42; 95% CI [0.23, 0.62]). Meta-regression analyses revealed that samples with more males show larger ES for amplitude of target stimuli, while the amount of medication was negatively associated with the ES for the latency of standards. CONCLUSIONS: The results obtained suggest that claims of reduced or augmented P200 in schizophrenia based on the sole examination of standard or target stimuli fail to consider the stimulus effect. SIGNIFICANCE: Quantification of effects for standard and target stimuli is a required first step to understand the nature of P200 deficits in schizophrenia.


Assuntos
Estimulação Acústica/classificação , Potenciais Evocados Auditivos/fisiologia , Potenciais Evocados/fisiologia , Esquizofrenia/fisiopatologia , Estimulação Acústica/métodos , Adulto , Estudos de Casos e Controles , Eletroencefalografia , Feminino , Humanos , Masculino , Tempo de Reação/fisiologia , Análise de Regressão
6.
Curr Med Res Opin ; 24(2): 349-58, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18081988

RESUMO

BACKGROUND: Previous analyses have shown that long-acting risperidone (LAR) is cost-effective in several Western countries. In Portugal, however, the costs of key services are lower. Therefore, available evidence in other countries may have limited relevance. OBJECTIVE: To estimate costs and effects of LAR versus a conventional depot and a short-acting oral atypical antipsychotic over a 5-year period in Portugal. METHODS: An existing discrete event model was adapted to reflect the Portuguese healthcare setting, based on expert opinion, clinical, epidemiological, and cost data. The model compares three scenarios. In scenario 1, patients start with a conventional depot; in scenario 2, with LAR; and in scenario 3, with oral risperidone. The model simulates individual patient histories while taking into account patient characteristics such as risk to society and side-effects. Subsequently, the model simulates patient histories in terms of outpatient appointments, psychotic episodes, treatment, compliance, symptom scores, lack of ability to take care presenting an actual risk, and treatment setting. Outcomes were number of psychotic episodes, cumulative symptom score and direct medical costs. Univariate sensitivity analyses were carried out. RESULTS: Compared to a conventional depot and an oral atypical, LAR was estimated to save approximately euro 3603 and euro 4682 per patient (respectively) and avoid 0.44 and 0.59 relapses per patient in 5 years. Sensitivity analyses showed that the outcome of dominance was only sensitive to estimates about unit costs of hospital/institutionalization, potential risk, and to the reduction in symptoms by use of atypicals. CONCLUSION: Based on this modeling exercise, it could be expected that LAR may be a cost-effective treatment with limited budget impact in Portugal. However, further studies are required to test the generalizability of the results of the present modeling study to the larger population of Portugal.


Assuntos
Antipsicóticos/economia , Transtornos Psicóticos/tratamento farmacológico , Risperidona/economia , Antipsicóticos/farmacologia , Antipsicóticos/uso terapêutico , Orçamentos , Análise Custo-Benefício , Preparações de Ação Retardada/economia , Custos de Medicamentos , Hospitalização/economia , Humanos , Modelos Econométricos , Avaliação de Resultados em Cuidados de Saúde , Portugal , Testes Psicológicos , Psicometria , Risperidona/farmacologia , Risperidona/uso terapêutico , Inquéritos e Questionários , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...